U.S. Intrauterine Devices Market Size By Product (Copper IUD, Hormonal IUD), By Age Group (15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45+), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024

Published Date: Sep 2018  |  Report ID: GMI2895  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 220   |   Base Year: 2017

Summary Table of Contents Industry Coverage Methodology

Industry Trends

U.S. Intrauterine Devices Market size was valued over USD 1.2 billion in 2017 and is expected to witness more than 7.5% CAGR from 2018 to 2024.

U.S. Intrauterine Devices Market

Get more details on this report - Request Free Sample PDF

Rising awareness in women population regarding various application of intrauterine devices will drive the industry growth in the future. Unintended pregnancy remains a widespread issue in the United States, enveloping around fifty percent of the annual six million pregnancies in the country and major reason for increasing IUD demand. Recent evidences have shown a slight rebirth in the use of intrauterine devices in the country. Health educators are raising awareness and spreading knowledge about various IUD applications among the providers and potential users through programs; thus, resulting in augmenting demand for various intra-uterine devices.

Government initiatives to prevent unintended pregnancies and growing population base creating massive demand for contraceptives will fuel the market size. For example; the Affordable Care Act suitably recognizes contraception as a vital preventive health service for women, and requires all new coverage plans to provide reimbursement of the full range of FDA-approved contraceptives without cost-sharing for women.

High cost of the intrauterine device may hamper the IUD industry over the forecast period. For un-insured consumers, intrauterine device cost up to USD 1000. High cost of the device and additional cost required to remove and insert the IUD device might not be affordable to few of the customers.

U.S. Intrauterine Devices Market Report Coverage
Report Coverage Details
Base Year: 2017 Market Size in 2017: 1.2 Billion (USD)
Historical Data for: 2013 to 2017 Forecast Period: 2018 to 2024
Forecast Period 2018 to 2024 CAGR: 7.5% 2024 Value Projection: 2 Billion (USD)
Pages: 220 Tables, Charts & Figures: 150
Geographies covered: East North Central {Illinois, Indiana, Michigan, Ohio, Wisconsin}, West South Central {Arkansas, Louisiana, Oklahoma, Texas}, South Atlantic {Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, Washington, D.C}, North East {Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, Pennsylvania}, East South Central {Alabama, Kentucky, Mississippi, Tennessee}, West North Central {Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, South Dakota}, Pacific Central {Alaska, California, Hawaii, Oregon, Washington}, Mountain States {Arizona, Colorado, Utah, Nevada, New Mexico, Idaho, Montana, Wyoming}
Segments covered: Product, Age Group and Region
Companies covered (2): Bayer, Teva Pharmaceutical
Growth Drivers:
  • Favorable regulatory scenario
  • Rising awareness among U.S. women regarding various IUD applications
  • High number of unintended pregnancies
  • Government initiatives for the prevention of unwanted abortions and pregnancies
  • Growing inclination towards planned delayed pregnancy
Pitfalls & Challenges:
  • High cost of device
  • Risk of several health issues
  • Variability in insurance coverage and access

Get more details on this report - Request Free Sample PDF

U.S. Intrauterine Devices Market, By Product

Hormonal intrauterine device market is estimated to show robust in the foreseeable future, expanding at a CAGR of 8.2% over the forecast period. Currently, there are four hormonal IUDs in the available in U.S. market; they are, Mirena, Skyla, Kyleena and Lillete. Some of the advantages that drive hormonal IUD market are lowering menstrual bleeding, stopping periods in some cases, being oestrogen free and lasts for long period of time. Moreover, they are nearly 99% effective in preventing conception, reversible, and starts working almost immediately, as claimed by some of the recent research studies. These varied advantages of the hormonal intrauterine device will boost the growth of U.S. IUD market in near future.

Copper intrauterine device was valued at USD 173.0 million in the year 2017. Copper IUD is largely preferred by the women that are looking for hormone-free alternatives for preventing pregnancy and do not want to use hormonal intrauterine device because of the possible side effects. Also, it offers long-term prevention against pregnancy; nearly 10 to 12 years after implantation and does not present any harm to the normal functioning of the endocrine system.

U.S. Intrauterine Devices Market, By Age Group

Women in the age group 30 to 34 years were major IUD customers and responsible for around USD 296.4 million market 2017. According to the recent data from Centres for Disease Control and Prevention (CDC), use of IUD is highest among the women aged between 25 to 34; over 50% higher than the normal usage rate in women aged 20 to 24. Rise in number of women opting for planned delayed pregnancies in the country will increase the IUD adoption rate, fuelling the U.S. intrauterine device industry growth.

IUD market for women in the age group 25 to 29 years is expand at a CAGR of 7.9% during forecast period. As per the recent news, majority of the women aged around 25 to 29 are shifting towards IUD from other contraceptive methods. Long-acting reversible contraceptives have several advantages over other forms of birth control, such as pill and condoms. This shift will increase the number of women opting for intrauterine device thereby, boosting the U.S. intrauterine device marker growth.

U.S. Intrauterine Devices Market, By Zone

South Atlantic zone held majority of market share in total U.S. IUD market and was valued over USD 251.8 million in 2017. According to findings, in 2013 around 50% of all the pregnancies in Florida were unintended. Increase in number of teen births and unintended pregnancies in the major states of South Atlantic zone such as Florida, North Carolina and Georgia will increase the adoption and use of intrauterine devices among the women, resulting in IUD industry growth.

IUD market in West North Central zone is projected to expand at CAGR of 7.7% over the forecast period. The adolescent pregnancy rate in Iowa was around 39 per 1,000 in the year 2013. The increase in number of adolescent pregnancy rate in states of Iowa, Minnesota and Missouri will increase the adoption rate and demand for contraceptives such as intrauterine devices augment the business growth in the region.

Competitive Market Share

Leading manufactures of intrauterine device in the Unites States are Bayer and Teva Pharmaceutical. These companies majorly focus on manufacturing and launching of innovative intrauterine devices in order to expand their product portfolio. Bayer AG launched hormonal IUD Kyleena in the year 2016 and got U.S. FDA approval the sales and distribution of hormonal IUD in the country.

U.S. Intrauterine Devices Industry Background  

Intrauterine devices are one of the most effective reversible contraception for women, but the usage of intrauterine device is relatively lower in the United States as compared to that of the other eastern countries. IUDs are being used in U.S. from many years, however due to some safety issues and controversies in 1970s all but one intrauterine device was prompted to be removed from the U.S. market by 1986. In 1988, the first new generation intrauterine device was launched in the U.S. market after revised U.S. FDA safety and manufacturing requirements. As per the research conducted by Kaiser Family Foundation, the usage of IUD among the women age between 15 and 44 has increased substantially in the last few years. Increase in government initiatives such as implementation of Affordable Care Act, elimination of high cost of IUDs and, rise in awareness and acceptance of IUDs among the women and providers is expected to increase the use and adoption of intrauterine device among the women with potential to minimize the number of unintended pregnancies in the country.

Frequently Asked Questions (FAQ) :

The market size of U.S. intrauterine devices crossed USD 1.2 billion in 2017.
The industry share of U.S. intrauterine devices is expected to witness more than 7.5% CAGR from 2018 to 2024.

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Sep 2018
  • Pages: 220
  • Tables: 141
  • Charts / Figures: 9
  • Companies covered: 2
  • States covered: 52

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X